IL22 and myeloid sarcoma: The pathogenesis of MS is marked by the existence of pro‐inflammatory self‐reactive T cells, including T‐helper 1 (Th1), Th17, and Th22 cells producing interferon gamma (IFN‐γ), interleukin 17 (IL‐17), and IL‐22.